Neonates with vein of Galen aneurysmal malformation (VGAM) present with a variety of systemic and pulmonary cardiovascular manifestations due to high-volume preductal left-to-right shunt. In utero maldevelopment of the pulmonary vascular bed due to overcirculation may lead to severe pulmonary hypertension (PH), 1 presenting at birth as hypoxic respiratory failure. 
Neonates with vein of Galen aneurysmal malformation (VGAM) present with a variety of systemic and pulmonary cardiovascular manifestations due to high-volume preductal left-to-right shunt. In utero maldevelopment of the pulmonary vascular bed due to overcirculation may lead to severe pulmonary hypertension (PH), 1 presenting at birth as hypoxic respiratory failure. The postnatal cardiovascular course represents a pathophysiologic continuum from asymptomatic to the progressive development of hypotension, and impaired organ perfusion. Studies have shown that early neonatal cardiovascular decompensation is a marker of poor outcome with a high mortality rate without treatment. 2 Treatment using staged endovascular embolization requires admission to a specialized center; however, attaining cardiovascular stability prior to embolization may be challenging. 3 These patients represent a unique population, rarely seen by most neonatologists. The clinical presentation and degree of hemodynamic compromise may be variable meriting standardization of the approach to assessment and therapeutic intervention. Targeted neonatal echocardiography (TnECHO) by trained neonatologists is used
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Abstract
Vein of Galen malformation results in predictable changes in physiology which exist on a continuum. Severe pulmonary hypertension may present as hypoxemia; however, excessive reduction in pulmonary vascular resistance may precipitate progressive pulmonary overcirculation and impaired systemic blood flow. Right ventricular performance and the patency and direction of the ductus arteriosus may play a crucial role in postductal organ perfusion. Physiological stabilization may be complex and variable over time. The utilization of targeted neonatal echocardiography to guide treatment decisions may improve the ability to provide therapy tailored to the specific disease pathophysiology and monitor serially as conditions change. An enhanced approach to physiological stabilization may reduce the risk of unexpected decompensation and allow for thoughtful, controlled endovascular embolization in appropriate candidates.
in many centers across the world to manage pulmonary and systemic hemodynamics. large right-to-left DA with normal RV performance and RVO: LVO of 1.4. Once stable, weaning cardiovascular support was attempted but due to recurrence of poor perfusion and severe RV dysfunction, he underwent successful VGAM embolization with symptomatic improvement.
Case 2
A female infant was born by vaginal delivery following an uncomplicated pregnancy at 37 weeks with a birth weight of 2.4 kg. Shortly after delivery, she was noticed to be visibly cyanotic with right hand oxygen saturation (SpO 2 ) of 70%. She required 3 L of flow via nasal canula in FiO 2 of 1.0 to achieve a preductal SpO 2 of 90%. Pre-and postductal arterial pressures were 52/29 (37), right arm and right leg were 41/35 (37), respectively. She was transferred to the local tertiary NICU at 4 hours postnatal age where she was placed on CPAP in FiO 2 of 0.5. An anatomic echocardiogram was done due to suspicion of congenital heart disease. A large DA with right-to-left shunt and a dilated right heart with normal biventricular systolic performance was thought to be in keeping with transitional circulation. On postnatal day 2, a head ultrasound, done to evaluate decreased tone, was suggestive of VGAM. Despite initiation of furosemide, she remained oliguric and a capillary blood gas demonstrated evidence of metabolic acidosis (pH of 7.14, CO 2 of 48, and HCO 3 of 15). She was electively intubated for transport to an embolization center. Upon arrival to our center, she was noted to be critically unwell; specifically, she remained ventilated on moderate settings in FiO 2 of 0.65 and had low preductal systolic arterial pressure, oliguria, and elevated lactate (►Table 2). TnECHO evaluation demonstrated a small, restrictive right-to-left DA with moderateto-severe RV dysfunction and RVO:LVO ratio of 1.5 (►Table 2). An intravenous infusion of dobutamine was initiated at a dose of 5 µg/kg/min and increased to 10 µg/kg/min, but only with modest improvement after 4 hours; therefore, prostaglandin E 1 was added. FiO 2 subsequently declined to 0.45 with concomitant improvement in arterial pressure, urine output, and lactate. On postnatal day 3, she was transferred to the radiology department for MRI of the brain. During the procedure, she acutely desaturated to preductal SpO 2 of 75%, despite FiO 2 of 1.0 and iNO which had been started empirically a priori. Subsequent TnECHO demonstrated a large, exclusively right-to-left DA with normal RV systolic performance and high RVO with an RVO:LVO of 2.4 (►Table 2). Despite attaining clinical stability, the multidisciplinary team of a neonatologist, neurologist, neurosurgeon, and neurointerventionalist recommended withdrawal of intensive care based on severe white matter disease and poor neurological prognosis. 
Discussion
The immediate postnatal period is a time of physiological metamorphosis when changing pulmonary and systemic vascular resistance (SVR) are essential adaptations. The clinical presentation of VGAM in newborns represents a spectrum with multiple pathophysiological changes which may contribute to poor tissue oxygen delivery. The approach to treatment of these patients requires careful physiologic delineation. Possible contributors to instability include impaired RV performance, low pulmonary blood flow due to high pulmonary vascular resistance, and pseudocoarctation physiology (►Table 3). First, both high pulmonary blood flow with subsequent pulmonary vascular muscularization 9,10 with associated vascular hyperreactivity 11 contribute to high pulmonary pressure. Second, chronic volume loading leads to RV dilation and therefore increased susceptibility to afterload mediated dysfunction 12 and elevated energy demand. 13 Finally, intracranial steal may contribute to heart dysfunction via low coronary root pressure and is associated with retrograde descending aortic flow which may cause pseudocoarctation physiology. Balancing the VGAM circulation requires pulmonary pressure to be sufficiently low to avoid RV decompensation and impaired cardiac output but not so low as to exacerbate systemic steal either via the VGAM or via left-to-right ductal shunt. Changing pulmonary pressure may precipitate dramatic changes in cardiovascular physiology which are difficult to piece together clinically. The use of iNO to improve oxygenation, therefore, requires careful consideration of timing and frequent reassessment to avoid precipitating pseudocoarctation as in our first case. In contrast, the combination of highly reactive pulmonary vasculature and a vulnerable RV may precipitate dramatic pulmonary hypertensive crisis in which iNO may be invaluable as in our second case. Documentation of normal RV systolic performance prior to any noxious stimulus is recommended. We have developed an algorithm which recognizes the variance in phenotypic presentation and incorporates an approach to therapeutic intervention based on enhanced physiologic precision (►Fig. 1). Dobutamine has favorable properties as a relatively pure inotrope.
14 The avoidance of potent systemic vasoconstrictors (e.g., dopamine, epinephrine, norepinephrine, vasopressin) is recommended, unless there is an additional illness with low SVR such as sepsis. 15 Milrinone, a nonselective vasodilator, may cause dangerously low diastolic arterial pressure and compromise coronary and organ perfusion pressure. It may be considered cautiously, however, in the setting of increased LV exposed afterload following embolization to support myocardial performance. Prostaglandin has a dual role including RV afterload reduction and postductal delivery of systemic blood flow which may be relatively protected from the impact of intracranial steal. The ability to provide longitudinal assessment makes TnECHO an important tool in the acute management of these infants and may also provide insights into disease prognosis. It has been suggested that high combined cardiac output is associated with mortality in fetuses with VGAM, 16 and therefore, postnatal cardiac output may provide useful insight. Interestingly, both a higher ratio of RVO:LVO to achieve stable systemic blood flow and severe white matter injury were identified in the second case indicating a greater shunt magnitude. The complexity and delicate balance of disease pathophysiology illustrated in these cases highlight the importance of management of this rare disorder in centers with both the neurointerventional and neonatal hemodynamic experience to optimize their care.
